Literature DB >> 16984992

Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.

Yulia Grischuk1, Petr Rubtsov, Felix G Riepe, Joachim Grötzinger, Svetlana Beljelarskaia, Vladimir Prassolov, Natalya Kalintchenko, Tatyana Semitcheva, Valentina Peterkova, Anatoly Tiulpakov, Wolfgang G Sippell, Nils Krone.   

Abstract

CONTEXT: Congenital adrenal hyperplasia is a group of autosomal recessive inherited disorders of steroidogenesis. The most frequent cause is the deficiency of steroid 21-hydroxylase (CYP21) due to mutations in the CYP21A2 gene.
OBJECTIVE: We analyzed the functional and structural consequences of the four CYP21A2 missense mutations (C169R, G178R, W302R, and R426C) to prove their clinical relevance and study their impact on CYP21 function.
RESULTS: Analyzing the mutations in vitro revealed an almost absent or negligible CYP21 activity for the conversion of 17-hydroxyprogesterone to 11-deoxycortisol and progesterone to deoxycorticosterone. Protein translation and intracellular localization were not affected by the mutants, as could be demonstrated by Western blotting and immunofluorescence studies. Analysis of these mutants in a three-dimensional model structure of the CYP21 protein explained the observed in vitro effects because all the mutations severely interfere either directly or indirectly with important structures of the 21-hydroxylase protein.
CONCLUSION: The in vitro expression analysis of residual enzyme function is a complementary method to genotyping and an important tool for improving the understanding of the clinical phenotype of 21-hydroxylase deficiency. This forms the foundation for accurate clinical and genetic counseling and for prenatal diagnosis and treatment. Moreover, this report demonstrates that the combination of in vitro enzyme analysis and molecular modeling can yield novel insights into CYP450 structure-functional relationships.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984992     DOI: 10.1210/jc.2006-0777

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Gabriela P Finkielstain; Wuyan Chen; Sneha P Mehta; Frank K Fujimura; Reem M Hanna; Carol Van Ryzin; Nazli B McDonnell; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

Review 2.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

3.  Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.

Authors:  P Balraj; P G Lim; H Sidek; L L Wu; A S B Khoo
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 4.256

4.  Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia.

Authors:  Shozeb Haider; Barira Islam; Valentina D'Atri; Miriam Sgobba; Chetan Poojari; Li Sun; Tony Yuen; Mone Zaidi; Maria I New
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

5.  Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort.

Authors:  Nils Krone; Ian T Rose; Debbie S Willis; James Hodson; Sarah H Wild; Emma J Doherty; Stefanie Hahner; Silvia Parajes; Roland H Stimson; Thang S Han; Paul V Carroll; Gerry S Conway; Brian R Walker; Fiona MacDonald; Richard J Ross; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2013-01-21       Impact factor: 5.958

6.  A novel 9-bp insertion detected in steroid 21-hydroxylase gene (CYP21A2): prediction of its structural and functional implications by computational methods.

Authors:  Sudhisha Dubey; Susan Idicula-Thomas; Mohammad Anwaruddin; Chinnaraj Saravanan; R Raveendra Varma; Anurupa Maitra
Journal:  J Biomed Sci       Date:  2009-01-08       Impact factor: 8.410

7.  High frequency of copy number variations and sequence variants at CYP21A2 locus: implication for the genetic diagnosis of 21-hydroxylase deficiency.

Authors:  Silvia Parajes; Celsa Quinteiro; Fernando Domínguez; Lourdes Loidi
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.